Nxstage Medical (NXTM) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts NXTM Hot Sheet
Price: $30.00 --0%
Financial Fact:
Selling and marketing: 16.02M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Selling and marketing: 16.02M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Nxstage Medical (NASDAQ: NXTM) reported Q2 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $80.3 million versus the consensus estimate of $79.89 million.
For earnings history and earnings-related data on Nxstage Medical (NXTM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
